英文别名 |
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1R,2S)-rel-;(1R,2S)-REL-2-(AMINOMETHYL)-N,N-DIMETHYL-1-PHENYLCYCLOPROPANECARBOXAMIDE HYDROCHLORIDE;IXEL;F 2207;MILNACIPRAN;MILNACIPRAN HCL;MIDALCIPRAN;MIDALCIPRAN HYDROCHLORIDE;TOLEDOMIN;MILNACIPRAN HYDROCHLORIDE;MILNACIPRAN HYDROCHL;Milnacipran-d10;TN-912;Milborn;Milnace;(1R,2S)-rel-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide;(±)-Milnacipran;Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(±)- (ZCI);rel-(1R,2S)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide (ACI);Avermilan;Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-;Impulsor;DTXCID8028262;DTXCID8028262;HY-B0168;HY-B0168;CS-0003566;CS-0003566;UNII-G56VK1HF36;UNII-G56VK1HF36;(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide;(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide;Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-,(1R,2S)-rel-;Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-,(1R,2S)-rel-;CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1R,2S)-;CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1R,2S)-;N06AX17;N06AX17;CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1R,2S)-REL-;CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1R,2S)-REL-;96847-55-1;96847-55-1;F2696;F2696;ES1O38J3C4;ES1O38J3C4;DTXSID601025164;DTXSID601025164;G56VK1HF36;G56VK1HF36;AB00640027_06;AB00640027_06;Milnacipranum;Milnacipranum;Dextromilnacipran;Dextromilnacipran;NS00005402;NS00005402;(-)-milnacipran;(-)-milnacipran;BDBM86420;BDBM86420;BRD-K02227374-003-07-1;BRD-K02227374-003-07-1;SCHEMBL8099;SCHEMBL8099;MILNACIPRAN [WHO-DD];MILNACIPRAN [WHO-DD];MILNACIPRAN PIERRE FABRE MEDICAMENT;MILNACIPRAN PIERRE FABRE MEDICAMENT;(1R,2S)-MILNACIPRAN;(1R,2S)-MILNACIPRAN;MILNACIPRAN [EMA EPAR];MILNACIPRAN [EMA EPAR];(+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide;(+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide;EN300-18531191;EN300-18531191;MILNACIPRAN [MI];MILNACIPRAN [MI];(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide;(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide;C16729;C16729;Milnacipran (INN);Milnacipran (INN);HY-14794;HY-14794;DA-59410;DA-59410;(+-)-Milnacipran;(+-)-Milnacipran;NCGC00165825-01;NCGC00165825-01;D08222;D08222;92623-85-3;92623-85-3;CAS_92623-85-3;CAS_92623-85-3;MILNACIPRAN [VANDF];MILNACIPRAN [VANDF];(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropane-1-carboxamide;(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropane-1-carboxamide;Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(+-)-;Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(+-)-;F-2696;F-2696;CHEBI:94468;CHEBI:94468;Milnacipran [INN:BAN];Milnac... |